Risk for Death, Complications Higher With COVID-19 Versus Flu
Risk for mechanical ventilation use, admission to intensive care, longer length of stay increased for COVID-19 versus flu
Influenza
Xofluza Approved for Postexposure Prevention of Influenza
The approval was supported by data from the randomized, double-blind, placebo-controlled phase 3 Blockstone trial.
Certain HTN Meds May Cut Deaths From Influenza, Pneumonia
Use of ACE-I/ARB vs nonuse linked to lower mortality for those hospitalized with flu, pneumonia.
Discussing Flu and Pneumococcal Vaccines With Patients During COVID-19
Considering COVID-19 has dominated the news all across the world, some people could have been distracted from other medical concerns that exist. And as flu season approaches, getting vaccinated is still something patients need to prioritize. Health officials in the United States have urged Americans to get influenza and pneumococcal vaccines, but recent data from…
Pimodivir Influenza Development Program Discontinued
The efficacy and safety of pimodivir, an inhibitor of influenza virus polymerase basic protein 2, was being investigated in two phase 3 studies.
In-Hospital Heart Failure Deaths Down With Routine Vaccinations
Patients with heart failure receiving flu, pneumonia vaccinations have lower in-hospital mortality
ACIP: Influenza Vaccination Recommendations for 2020-2021
Influenza vaccination should occur by the end of October, if possible.
Novel Rapid Influenza Diagnostic Test Demonstrates Good Sensitivity, Specificity
The Theraflu Home FluTest, a novel rapid influenza diagnostic test, demonstrated good sensitivity and specificity for both influenza A and B viruses.
Baloxavir Protects Household Contacts From Influenza
Percentage of patients in whom clinical influenza developed significantly lower in baloxavir group.
More Than 1 in 4 Parents Hesitant About Flu Vaccine
Seventy and 26% strongly agree that routine and flu vaccines are effective, respectively.
